Article

Enhancing KLF15 activity in cardiomyocytes: a novel approach to prevent pathological reprogramming and fibrosis via nuclease-deficient dCas9VPR.
Schoger, Eric, Kim, Rosa, Bleckwedel, Federico, Peralta, Tomas, Priesmeier, Laura, Fischer, Janek, Stengel, Laura, Rocha, Cheila, Santos, Gabriela L., Lutz, Susanne, Boileau, Etienne, Baumgarten, Nina, Schulz, Marcel H., Dieterich, Christoph, Müller, Oliver J., Cyganek, Lukas, Cabrera-Orefice, Alfredo, Eberl, Hanna, Maack, Christoph, Streckfuss-Bömeke, Katrin, Pavez-Giani, Mario, Doroudgar, Shirin, Sossalla, Samuel T. and Zelarayán, Laura C.
Signal Transduction and Targeted Therapy 11 (1): 76. 3 March 2026

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy.
Walther, W., Torke, S. and Stein, U.
Signal Transduction and Targeted Therapy 9 (1): 331. 26 November 2024

Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts.
Kolesnichenko, M. and Scheidereit, C.
Signal Transduction and Targeted Therapy 9 (1): 179. 29 July 2024

Editorial

Unraveling the RNA code: a uridine RNA modification drives glycoRNA biogenesis.
Sachse, M. and Stellos, K.
Signal Transduction and Targeted Therapy 9 (1): 334. 27 November 2024

Human embryo models: unveiling sophisticated self-organization of stem cells during post-implantation stages.
Lin, M. and Sigal, M.
Signal Transduction and Targeted Therapy 8 (1): 419. 6 November 2023